Specialty biopharmaceutical company.
Issues related to healthcare, including improving patient access to advanced immunology therapies; Issues related to policies affecting biopharma products coverage and access in Medicare and Medicaid; Issues related to H.R.5376 - Build Back Better Act; Issues related to drug pricing. Issues related to H.R.2471 - Consolidated Appropriations Act, 2022. Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260); Issues related to H.R.2471 - Consolidated Appropriations Act, 2022.
HCR - Health Issues BUD - Budget/Appropriations
34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 12 - White House Office 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
FORBES-TATE
777 6th Street NW, 8th Floor, Washington, DC, 20001, US
BARRETT THORNHILL ZACHARY WILLIAMS JEFFREY FORBES ELIZABETH GREER DERRICK M WHITE CYNTHIA BROWN BARRETT THORNHILL ZACHARY WILLIAMS JEFFREY FORBES ELIZABETH GREER CYNTHIA BROWN DERRICK M WHITE